Impact of extent of resection for recurrent glioblastoma on overall survival: clinical article
- PMID: 23039151
- DOI: 10.3171/2012.9.JNS12504
Impact of extent of resection for recurrent glioblastoma on overall survival: clinical article
Abstract
Object: Extent of resection (EOR) has been shown to be an important prognostic factor for survival in patients undergoing initial resection of glioblastoma (GBM), but the significance of EOR at repeat craniotomy for recurrence remains unclear. In this study the authors investigate the impact of EOR at initial and repeat resection of GBM on overall survival.
Methods: Medical records were reviewed for all patients undergoing craniotomy for GBM at the University of California San Francisco Medical Center from January 1, 2005, through August 15, 2009. Patients who had a second craniotomy for pathologically confirmed recurrence following radiation and chemotherapy were evaluated. Volumetric EOR was measured and classified as gross-total resection (GTR, > 95% by volume) or subtotal resection (STR, ≤ 95% by volume) after independent radiological review. Overall survival was compared between groups using univariate and multivariate analysis accounting for known prognostic factors, including age, eloquent location, Karnofsky Performance Status (KPS), and adjuvant therapies.
Results: Multiple resections were performed in 107 patients. Fifty-two patients had initial GTR, of whom 31 (60%) had GTR at recurrence, with a median survival of 20.4 months (standard error [SE] 1.0 months), and 21 (40%) had STR at recurrence, with a median survival of 18.4 months (SE 0.5 months) (difference not statistically significant). Initial STR was performed in 55 patients, of whom 26 (47%) had GTR at recurrence, with a median survival of 19.0 months (SE 1.2 months), and 29 (53%) had STR, with a median survival of 15.9 months (SE 1.2 months) (p = 0.004). A Cox proportional hazards model was constructed demonstrating that age (HR 1.03, p = 0.004), KPS score at recurrence (HR 2.4, p = 0.02), and EOR at repeat resection (HR 0.62, p = 0.02) were independent predictors of survival. Extent of initial resection was not a statistically significant factor (p = 0.13) when repeat EOR was included in the model, suggesting that GTR at second craniotomy could overcome the effect of an initial STR.
Conclusions: Extent of resection at recurrence is an important predictor of overall survival. If GTR is achieved at recurrence, overall survival is maximized regardless of initial EOR, suggesting that patients with initial STR may benefit from surgery with a GTR at recurrence.
Comment in
-
Overall survival benefit from surgical resection in treatment of recurrent glioblastoma.Ann Oncol. 2014 Sep;25(9):1866-1867. doi: 10.1093/annonc/mdu243. Epub 2014 Jul 10. Ann Oncol. 2014. PMID: 25015331 Free PMC article. No abstract available.
-
Letter to the Editor: Biases in estimation of overall survival in patients who underwent repeat resection of glioblastoma.J Neurosurg. 2016 Aug;125(2):519-22. doi: 10.3171/2015.11.JNS152515. Epub 2016 Jun 3. J Neurosurg. 2016. PMID: 27257842 No abstract available.
Similar articles
-
Surgical outcome and molecular pattern characterization of recurrent glioblastoma multiforme: A single-center retrospective series.Clin Neurol Neurosurg. 2021 Aug;207:106735. doi: 10.1016/j.clineuro.2021.106735. Epub 2021 Jun 8. Clin Neurol Neurosurg. 2021. PMID: 34119900
-
Survival outcomes following repeat surgery for recurrent glioblastoma: a single-center retrospective analysis.J Neurooncol. 2017 Feb;131(3):585-591. doi: 10.1007/s11060-016-2330-7. Epub 2016 Nov 14. J Neurooncol. 2017. PMID: 27844310
-
Glioblastoma in the elderly: the effect of aggressive and modern therapies on survival.J Neurosurg. 2016 Apr;124(4):998-1007. doi: 10.3171/2015.4.JNS142200. Epub 2015 Oct 9. J Neurosurg. 2016. PMID: 26452121
-
Survival Benefit of Maximal Resection for Glioblastoma Reoperation in the Temozolomide Era: A Meta-Analysis.World Neurosurg. 2019 Jul;127:31-37. doi: 10.1016/j.wneu.2019.03.250. Epub 2019 Apr 1. World Neurosurg. 2019. PMID: 30947000 Review.
-
Aggressive repeat surgery for focally recurrent primary glioblastoma: outcomes and theoretical framework.Neurosurg Focus. 2015 Mar;38(3):E11. doi: 10.3171/2014.12.FOCUS14726. Neurosurg Focus. 2015. PMID: 25727220 Review.
Cited by
-
Surgical Treatment of Glioblastoma: State-of-the-Art and Future Trends.J Clin Med. 2022 Sep 13;11(18):5354. doi: 10.3390/jcm11185354. J Clin Med. 2022. PMID: 36143001 Free PMC article. Review.
-
Clinical Outcome of Cytoreductive Surgery Prior to Bevacizumab for Patients with Recurrent Glioblastoma: A Single-center Retrospective Analysis.Neurol Med Chir (Tokyo). 2021 Apr 15;61(4):245-252. doi: 10.2176/nmc.oa.2020-0308. Epub 2021 Mar 4. Neurol Med Chir (Tokyo). 2021. PMID: 33658457 Free PMC article.
-
Tractography for Subcortical Resection of Gliomas Is Highly Accurate for Motor and Language Function: ioMRI-Based Elastic Fusion Disproves the Severity of Brain Shift.Cancers (Basel). 2021 Apr 9;13(8):1787. doi: 10.3390/cancers13081787. Cancers (Basel). 2021. PMID: 33918598 Free PMC article.
-
The value of intraoperative ultrasonography during the resection of relapsed irradiated malignant gliomas in the brain.Ultrasonography. 2017 Jan;36(1):60-65. doi: 10.14366/usg.16015. Epub 2016 Aug 8. Ultrasonography. 2017. PMID: 27776402 Free PMC article.
-
High Precision Imaging of Microscopic Spread of Glioblastoma with a Targeted Ultrasensitive SERRS Molecular Imaging Probe.Theranostics. 2016 May 7;6(8):1075-84. doi: 10.7150/thno.13842. eCollection 2016. Theranostics. 2016. PMID: 27279902 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical